372 related articles for article (PubMed ID: 22270372)
1. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP.
Niwa H; Ewens CA; Tsang C; Yeung HO; Zhang X; Freemont PS
J Biol Chem; 2012 Mar; 287(11):8561-70. PubMed ID: 22270372
[TBL] [Abstract][Full Text] [Related]
2. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation.
Halawani D; LeBlanc AC; Rouiller I; Michnick SW; Servant MJ; Latterich M
Mol Cell Biol; 2009 Aug; 29(16):4484-94. PubMed ID: 19506019
[TBL] [Abstract][Full Text] [Related]
3. A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants.
Tang WK; Li D; Li CC; Esser L; Dai R; Guo L; Xia D
EMBO J; 2010 Jul; 29(13):2217-29. PubMed ID: 20512113
[TBL] [Abstract][Full Text] [Related]
4. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.
Wang Q; Song C; Yang X; Li CC
J Biol Chem; 2003 Aug; 278(35):32784-93. PubMed ID: 12807884
[TBL] [Abstract][Full Text] [Related]
5. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.
Chou TF; Bulfer SL; Weihl CC; Li K; Lis LG; Walters MA; Schoenen FJ; Lin HJ; Deshaies RJ; Arkin MR
J Mol Biol; 2014 Jul; 426(15):2886-99. PubMed ID: 24878061
[TBL] [Abstract][Full Text] [Related]
6. Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants.
Tang WK; Xia D
J Biol Chem; 2013 Dec; 288(51):36624-35. PubMed ID: 24196964
[TBL] [Abstract][Full Text] [Related]
7. Role of the D1-D2 Linker of Human VCP/p97 in the Asymmetry and ATPase Activity of the D1-domain.
Tang WK; Xia D
Sci Rep; 2016 Jan; 6():20037. PubMed ID: 26818443
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional roles of the conserved Arg residues in the second region of homology of p97/valosin-containing protein.
Wang Q; Song C; Irizarry L; Dai R; Zhang X; Li CC
J Biol Chem; 2005 Dec; 280(49):40515-23. PubMed ID: 16216872
[TBL] [Abstract][Full Text] [Related]
9. Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region.
Song C; Wang Q; Song C; Lockett SJ; Colburn NH; Li CC; Wang JM; Rogers TJ
Biochim Biophys Acta; 2015 Jan; 1853(1):222-32. PubMed ID: 25447673
[TBL] [Abstract][Full Text] [Related]
10. Altered cofactor regulation with disease-associated p97/VCP mutations.
Zhang X; Gui L; Zhang X; Bulfer SL; Sanghez V; Wong DE; Lee Y; Lehmann L; Lee JS; Shih PY; Lin HJ; Iacovino M; Weihl CC; Arkin MR; Wang Y; Chou TF
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1705-14. PubMed ID: 25775548
[TBL] [Abstract][Full Text] [Related]
11. ATP-bound form of the D1 AAA domain inhibits an essential function of Cdc48p/p97.
Esaki M; Ogura T
Biochem Cell Biol; 2010 Feb; 88(1):109-17. PubMed ID: 20130684
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal Region of the Ubiquitin Regulatory X (UBX) Domain-containing Protein 1 (UBXD1) Modulates Interdomain Communication within the Valosin-containing Protein p97.
Trusch F; Matena A; Vuk M; Koerver L; Knævelsrud H; Freemont PS; Meyer H; Bayer P
J Biol Chem; 2015 Dec; 290(49):29414-27. PubMed ID: 26475856
[TBL] [Abstract][Full Text] [Related]
13. Conserved L464 in p97 D1-D2 linker is critical for p97 cofactor regulated ATPase activity.
Zhang X; Gui L; Li S; Nandi P; Columbres RC; Wong DE; Moen DR; Lin HJ; Chiu PL; Chou TF
Biochem J; 2021 Sep; 478(17):3185-3204. PubMed ID: 34405853
[TBL] [Abstract][Full Text] [Related]
14. Conformational changes of p97 during nucleotide hydrolysis determined by small-angle X-Ray scattering.
Davies JM; Tsuruta H; May AP; Weis WI
Structure; 2005 Feb; 13(2):183-95. PubMed ID: 15698563
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional deviations in disease-associated p97 mutants.
Tang WK; Xia D
J Struct Biol; 2012 Aug; 179(2):83-92. PubMed ID: 22579784
[TBL] [Abstract][Full Text] [Related]
17. ATP binding to p97/VCP D1 domain regulates selective recruitment of adaptors to its proximal N-domain.
Chia WS; Chia DX; Rao F; Bar Nun S; Geifman Shochat S
PLoS One; 2012; 7(12):e50490. PubMed ID: 23226521
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.
Wang T; Xu W; Qin M; Yang Y; Bao P; Shen F; Zhang Z; Xu J
J Biol Chem; 2016 Jul; 291(27):14373-14384. PubMed ID: 27226613
[TBL] [Abstract][Full Text] [Related]
19. Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities.
Wang Q; Song C; Li CC
Biochem Biophys Res Commun; 2003 Jan; 300(2):253-60. PubMed ID: 12504076
[TBL] [Abstract][Full Text] [Related]
20. Valosin-containing protein (VCP) is a novel IQ motif-containing GTPase activating protein 1 (IQGAP1)-interacting protein.
Itoh N; Nagai T; Watanabe T; Taki K; Nabeshima T; Kaibuchi K; Yamada K
Biochem Biophys Res Commun; 2017 Dec; 493(4):1384-1389. PubMed ID: 28970065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
